Your browser doesn't support javascript.
loading
First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.
Walewski, Jan; Paszkiewicz-Kozik, Ewa; Michalski, Wojciech; Rymkiewicz, Grzegorz; Szpila, Tomasz; Butrym, Aleksandra; Giza, Agnieszka; Zaucha, Jan M; Kalinka-Warzocha, Ewa; Wieczorkiewicz, Agata; Zimowska-Curylo, Dagmara; Knopinska-Posluszny, Wanda; Tyczynska, Agata; Romejko-Jarosinska, Joanna; Dabrowska-Iwanicka, Anna; Gruszecka, Beata; Jamrozek-Jedlinska, Maria; Borawska, Anna; Holda, Waldemar; Porowska, Agnieszka; Romanowicz, Agnieszka; Hellmann, Andrzej; Stella-Holowiecka, Beata; Deptala, Andrzej; Jurczak, Wojciech.
Afiliação
  • Walewski J; Maria Sklodowska-Curie Institute - Oncology Center in Warsaw, Warsaw, Poland.
  • Paszkiewicz-Kozik E; Maria Sklodowska-Curie Institute - Oncology Center in Warsaw, Warsaw, Poland.
  • Michalski W; Maria Sklodowska-Curie Institute - Oncology Center in Warsaw, Warsaw, Poland.
  • Rymkiewicz G; Maria Sklodowska-Curie Institute - Oncology Center in Warsaw, Warsaw, Poland.
  • Szpila T; Institute of Hematology and Transfusiology, Warsaw, Poland.
  • Butrym A; Medical University Wroclaw, Wroclaw, Poland.
  • Giza A; Jagiellonian University Collegium Medicum, Krakow, Poland.
  • Zaucha JM; Medical University Gdansk, Gdansk, Poland.
  • Kalinka-Warzocha E; Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland.
  • Wieczorkiewicz A; Silesian Medical University, Katowice, Poland.
  • Zimowska-Curylo D; Medical University Wroclaw, Wroclaw, Poland.
  • Knopinska-Posluszny W; Maritime Hospital, Gdynia, Poland.
  • Tyczynska A; Maritime Hospital, Gdynia, Poland.
  • Romejko-Jarosinska J; Maria Sklodowska-Curie Institute - Oncology Center in Warsaw, Warsaw, Poland.
  • Dabrowska-Iwanicka A; Maria Sklodowska-Curie Institute - Oncology Center in Warsaw, Warsaw, Poland.
  • Gruszecka B; Lower Silesia Cell Transplantation Center, Wroclaw, Poland.
  • Jamrozek-Jedlinska M; Municipal Hospital, Poznan, Poland.
  • Borawska A; Maria Sklodowska-Curie Institute - Oncology Center in Warsaw, Warsaw, Poland.
  • Holda W; Subcarpathian Voivodeship Hospital, Krosno, Poland.
  • Porowska A; Central Clinical Hospital of the MSWiA, Warsaw, Poland.
  • Romanowicz A; Central Clinical Hospital of the MSWiA, Warsaw, Poland.
  • Hellmann A; Medical University Gdansk, Gdansk, Poland.
  • Stella-Holowiecka B; Silesian Medical University, Katowice, Poland.
  • Deptala A; Central Clinical Hospital of the MSWiA, Warsaw, Poland.
  • Jurczak W; Medical University of Warsaw, Warsaw, Poland.
Br J Haematol ; 188(6): 898-906, 2020 03.
Article em En | MEDLINE | ID: mdl-31792945

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vincristina / Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Ciclofosfamida / Rituximab / Imunoterapia Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Haematol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Polônia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vincristina / Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Ciclofosfamida / Rituximab / Imunoterapia Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Haematol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Polônia